Published in

Nature Research, Nature, 7510(511), p. 421-427, 2014

DOI: 10.1038/nature13595

Links

Tools

Export citation

Search in Google Scholar

Biological insights from 108 schizophrenia-associated genetic loci

Journal article published in 2014 by Drapeau Elodie, Stephan Ripke, James T. R. Walters, Pers Th, Chan Rc, Chen Ry, Bacanu Sa, Belliveau Jr Ra, Kahn Rs, Bergen Se, C. Robert Cloninger, Lieuwe de Haan, Lee Sh, Legge Se, Bigdeli Tb and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.